Subscribe to Newsletter
Business & Regulation Advanced Medicine, Standards & Regulation

FDA Accelerated Approval Pathways for Cell and Gene Therapy products

sponsored by Thermo Fisher Scientific

Available On-Demand

June 22, 2020 | 11am EDT / 4pm BST / 5pm CEST

The cell and gene therapy regulatory landscape is rapidly evolving. Join this webinar to discover the approaches available to this industry to accelerate the approval of cell and gene therapy products by discussing early FDA engagement opportunities, identifying the different approval pathways taken by the Agency to bring products to market quickly, and examining the recent cell and gene therapy guidances issued by the FDA.

Learning Objectives

  • Cell and gene therapy regulatory landscape.
  • The different types of FDA expedited pathways available.
  • Recent cell and gene therapy guidances issued.

Available On-Demand

Visit our Webinar Hub

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine